Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities and other Long-Term Liabilities (Narrative) (Details)

v3.21.1
Accrued Liabilities and other Long-Term Liabilities (Narrative) (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Initial discount for imputed interest $ 200,000   $ 200,000
Long-term notes payable, net (Journey) $ 51,986,000   51,677,000
Effective interest rate used to calculated imputed interest discount (in percent) 4.00%    
Period of effective interest rate considered for calculation of imputed interest discount (in years) 3 years    
Amortization of interest discount $ 309,000 $ 747,000  
Ximino [Member]      
Initial discount for imputed interest 1,200,000   1,400,000
Notes payable, short-term 2,000,000.0   2,000,000.0
Oral Acne Product (Isotretinoin) [Member]      
Notes payable, short-term 1,500,000   500,000
Anti-itch Product [Member]      
Initial discount for imputed interest $ 37,000   100,000
Effective interest rate used to calculated imputed interest discount (in percent) 4.25%    
Period of effective interest rate considered for calculation of imputed interest discount (in years) 3 years    
Notes payable, short-term $ 2,000,000.0   $ 2,800,000